DOCSLIB.ORG

Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Cellular/Molecular Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release Emilia Servián-Morilla1,2, Estefanía Robles-Lanuza1,2, Ana C. Sánchez-Hidalgo1,2, Rafael J. Camacho- Garcia1,2, Juan A. Paez-Gomez1,2, Fabiola Mavillard1,2,3, Carlos A. Saura3,4, Amalia Martinez-Mir1 and Francisco G. Scholl1,2 1Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain 2Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain 3Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain 4Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain DOI: 10.1523/JNEUROSCI.1357-17.2017 Received: 18 May 2017 Revised: 3 November 2017 Accepted: 26 November 2017 Published: 11 December 2017 Author contributions: E.S.-M., E.R.-L., and F.G.S. designed research; E.S.-M., E.R.-L., A.C.S.-H., and R.J.C.- G. performed research; E.S.-M., E.R.-L., A.C.S.-H., J.A.P.-G., A.M.-M., and F.G.S. analyzed data; F.M. and C.A.S. contributed unpublished reagents/analytic tools; A.M.-M. and F.G.S. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. This work was funded by grants from Junta de Andalucía (P11-CVI-7599) and MINECO (BFU2015-71464-R), co-funded by FEDER funds. E. S-M was a recipient of a fellowship from Junta de Andalucía. E. R-L is a fellow from V Plan Propio de Investigación (Universidad de Sevilla) and A. C. S-H received a fellowship from Junta de Andalucía. Part of the study was performed at CITIUS (Universidad de Sevilla). We thank J. Shen for providing fPS1/fPS1 and PS2 -/- mice and Cre constructs, D. Selkoe for PS1 vectors, L. Lagnado for the gift of the SypHy construct, and F.J. Morón from the IBiS Genomics Service for technical support. The authors wish to thank Dr. Rafael Fernández-Chacón for discussion and critical reading of the manuscript. Correspondence should be addressed to Francisco G. Scholl, Instituto de Biomedicina de Sevilla (IBiS), Avda Manuel Siurot s/n, 41013 Sevilla, Spain. E-mail address: [email protected] Cite as: J. Neurosci ; 10.1523/JNEUROSCI.1357-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published. Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreading process. Copyright © 2017 the authors 1 Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic 2 Vesicle Release 3 Abbreviated title: Processing of Neurexins and Presynaptic Release 4 Emilia Servián-Morilla1,2, Estefanía Robles-Lanuza1,2*, Ana C. Sánchez- 5 Hidalgo1,2*, Rafael J. Camacho-Garcia1,2, Juan A. Paez-Gomez1,2, Fabiola 6 Mavillard1,2,3, Carlos A. Saura3,4, Amalia Martinez-Mir1, Francisco G. Scholl1,2, 7 8 1Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del 9 Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain 10 2Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, 11 Universidad de Sevilla, 41009 Sevilla, Spain 12 3Centro de Investigación Biomédica en Red sobre Enfermedades 13 Neurodegenerativas (CIBERNED), Madrid, Spain 14 4Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, 15 Universitat Autònoma de Barcelona, 08193 Barcelona, Spain 16 *E.R.-L., A.C.S.-H. contributed equally to this work 17 Correspondence should be addressed to Francisco G. Scholl, Instituto de 18 Biomedicina de Sevilla (IBiS), Avda Manuel Siurot s/n, 41013 Sevilla, Spain. E- 19 mail address: [email protected] 20 21 Number of pages: 44 22 Number of figures: 9 23 Number of words for Abstract: 194 24 Number of words for Introduction: 650 25 Number of words for Discussion: 1417 1 26 The authors declare no competing financial interests 27 28 Acknowledgements 29 This work was funded by grants from Junta de Andalucía (P11-CVI-7599) and 30 MINECO (BFU2015-71464-R), co-funded by FEDER funds. E. S-M was a 31 recipient of a fellowship from Junta de Andalucía. E. R-L is a fellow from V Plan 32 Propio de Investigación (Universidad de Sevilla) and A. C. S-H received a 33 fellowship from Junta de Andalucía. Part of the study was performed at CITIUS 34 (Universidad de Sevilla). We thank J. Shen for providing fPS1/fPS1 and PS2 -/- 35 mice and Cre constructs, D. Selkoe for PS1 vectors, L. Lagnado for the gift of 36 the SypHy construct, and F.J. Morón from the IBiS Genomics Service for 37 technical support. The authors wish to thank Dr. Rafael Fernández-Chacón for 38 discussion and critical reading of the manuscript. 2 39 Abstract 40 Proteolytic processing of synaptic adhesion components can accommodate the 41 function of synapses to activity-dependent changes. The adhesion system 42 formed by Neurexins (Nrxns) and Neuroligins (Nlgns) bi-directionally 43 orchestrate the function of pre- and postsynaptic terminals. Previous studies 44 have shown that Presenilins (PS), components of the gamma-secretase 45 complex frequently mutated in familial Alzheimer’s disease, clear from 46 glutamatergic terminals the accumulation of Neurexin C-terminal fragments 47 (Nrxn-CTF) generated by ectodomain shedding. Here, we characterized the 48 synaptic consequences of the proteolytic processing of Nrxns in cultured 49 hippocampal neurons from mice and rats of both sexes. We show that 50 activation of presynaptic Nrxns with postsynaptic Neuroligin-1 (Nlgn1) or 51 inhibition of ectodomain shedding in axonal Nrxn1-beta increases presynaptic 52 release at individual terminals, likely reflecting an increase in the number of 53 functional release sites. Importantly, inactivation of PS inhibits presynaptic 54 release downstream of Nrxn activation, leaving synaptic vesicle recruitment 55 unaltered. Glutamate-receptor signaling initiates the activity-dependent 56 generation of Nrxn-CTF, which accumulates at presynaptic terminals lacking PS 57 function. Notably, the sole expression of Nrxn-CTF decreases presynaptic 58 release and calcium flux, recapitulating the deficits due to loss of PS function. 59 Our data indicate that inhibition of Nrxn processing by PS is deleterious to 60 glutamatergic function. 61 1 62 Significance statement 63 To gain insight into the role of Presenilins in excitatory synaptic function, we 64 address the relevance of the proteolytic processing of presynaptic Neurexins in 65 glutamatergic differentiation. Using synaptic fluorescence probes in cultured 66 hippocampal neurons we report that trans-synaptic activation of Neurexins 67 produces a robust increase in presynaptic calcium levels and neurotransmitter 68 release at individual glutamatergic terminals by a mechanism that depends on 69 normal PS activity. Abnormal accumulation of Neurexin C-terminal fragment 70 resulting from impaired Presenilin activity inhibits presynaptic calcium signal 71 and neurotransmitter release, assigning synaptic defects to Neurexins as a 72 specific Presenilin substrate. These data may provide links into how loss of 73 Presenilin activity inhibits glutamatergic synaptic function in Alzheimer’s disease 74 patients. 75 2 76 Introduction 77 Interaction between synaptic adhesion proteins mediates the formation and 78 function of synaptic contacts, as they organize supramolecular complexes at 79 both sides of the synapse. Proteolytic processing of synaptic proteins is a post- 80 translational mechanism that regulates the function of synapses upon activity- 81 dependent changes, whereas impairment of normal proteolytic processing often 82 results in synaptic dysfunction (Saura et al., 2004; Nagy et al., 2006; Huntley, 83 2012; Prox et al., 2013). Neurexins (Nrxn1, 2, 3) are presynaptic membrane 84 proteins that link neurotransmitter release with adhesion to postsynaptic 85 partners. The use of different promoters and alternative splicing at the 86 extracellular domain originate over one thousand Nrxn isoforms (Tabuchi and 87 Sudhof, 2002; Schreiner et al., 2014; Fuccillo et al., 2015; Schreiner et al., 88 2015). The highly polymorphic extracellular domain of Nrxns engages in trans- 89 synaptic interactions with postsynaptic proteins, whereas the conserved 90 cytoplasmic domain recruits synaptic ligands and regulates neurotransmitter 91 release (Boucard et al., 2005; Chih et al., 2006; Ko et al., 2009; Rabaneda et 92 al., 2014; Aoto et al., 2015). Neuroligins (Nlgn1, 2, 3, 4X, 4Y) are postsynaptic 93 partners of Nrxns that regulate several aspects of glutamatergic and GABAergic 94 differentiation (Ichtchenko et al., 1995; Baudouin and Scheiffele, 2010). At 95 glutamatergic synapses, Nlgn1 increases synapse density and stimulates 96 neurotransmitter release probability by a mechanism that depends on trans- 97 synaptic interaction with Nrxns (Dean et al., 2003; Chih et al., 2006; Futai et al., 98 2007). Mutations in NLGN3, NLGN4X and NRXN1 genes have been identified 99 in neurodevelopmental disorders, including autism and schizophrenia (Jamain 100 et al., 2003; Laumonnier et al., 2004; Kim et al., 2008; Rujescu et al., 2009; 3 101 Camacho-Garcia et al., 2012; Camacho-Garcia et al., 2013; Lowther et al., 102 2017), suggesting a causative role for synaptic dysfunction of Nrxns and Nlgns 103 in brain diseases. 104 Apart from their role in neurodevelopmental disorders, recent findings 105 suggest a malfunctioning of the Nrxn-Nlgn1 glutamatergic pathway in age- 106 associated diseases such as Alzheimer’s disease (AD) (Martinez-Mir et al., 107 2013; Bie et al., 2014; Sindi et al., 2014; Tristan-Clavijo et al., 2015). We and 108 others have shown that Presenilins (PS1, 2), the catalytic subunit of the 109 gamma-secretase complex mutated in familial AD (FAD), cleave the C-terminal 110 fragment (CTF) of Nlgn1 and Nrxn isoforms (Bot et al., 2011; Saura et al., 2011; 111 Peixoto et al., 2012; Suzuki et al., 2012).
Load more

Recommended publications
  • PSD-95 Binding Dynamically Regulates NLGN1 Trafficking and Function
    PSD-95 binding dynamically regulates NLGN1 trafficking and function Jaehoon Jeonga, Saurabh Pandeya, Yan Lia, John D. Badger IIa, Wei Lua, and Katherine W. Rochea,1 aNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved May 3, 2019 (received for review December 20, 2018) PSD-95 is a scaffolding protein that regulates the synaptic localization necessary for maintaining presynaptic release probability (15). of many receptors, channels, and signaling proteins. The NLGN gene Meanwhile, synaptic targeting of NLGN1 is known to be in- family encodes single-pass transmembrane postsynaptic cell adhesion dependent of PSD-95, as PSD-95 is recruited to the plasma molecules that are important for synapse assembly and function. At membrane after NLGN1 (13, 16, 17). In addition, non-PDZ excitatory synapses, NLGN1 mediates transsynaptic binding with ligand-dependent NLGN1 and NLGN3 functions have been in- neurexin, a presynaptic cell adhesion molecule, and also binds to vestigated (18), suggesting a complicated physiological interplay PSD-95, although the relevance of the PSD-95 interaction is not clear. between NLGNs and PSD-95. We now show that disruption of the NLGN1 and PSD-95 interaction Posttranslational modifications have been reported for several decreases surface expression of NLGN1 in cultured neurons. Further- NLGN isoforms and are postulated to confer distinct properties (11, more, PKA phosphorylates NLGN1 on S839, near the PDZ ligand, and 12). For example, phosphorylation of the cytoplasmic region of dynamically regulates PSD-95 binding. A phosphomimetic mutation NLGN1 has recently emerged as a mechanism for isoform-specific of NLGN1 S839 significantly reduced PSD-95 binding.
    [Show full text]
  • Autism-Associated Mir-873 Regulates ARID1B, SHANK3 and NRXN2
    Lu et al. Translational Psychiatry (2020) 10:418 https://doi.org/10.1038/s41398-020-01106-8 Translational Psychiatry ARTICLE Open Access Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment Jing Lu 1, Yan Zhu 1, Sarah Williams2, Michelle Watts 3,MaryA.Tonta1, Harold A. Coleman1, Helena C. Parkington1 and Charles Claudianos 1,4 Abstract Autism spectrum disorders (ASD) are highly heritable neurodevelopmental disorders with significant genetic heterogeneity. Noncoding microRNAs (miRNAs) are recognised as playing key roles in development of ASD albeit the function of these regulatory genes remains unclear. We previously conducted whole-exome sequencing of Australian families with ASD and identified four novel single nucleotide variations in mature miRNA sequences. A pull-down transcriptome analysis using transfected SH-SY5Y cells proposed a mechanistic model to examine changes in binding affinity associated with a unique mutation found in the conserved ‘seed’ region of miR-873-5p (rs777143952: T > A). Results suggested several ASD-risk genes were differentially targeted by wild-type and mutant miR-873 variants. In the current study, a dual-luciferase reporter assay confirmed miR-873 variants have a 20-30% inhibition/dysregulation effect on candidate autism risk genes ARID1B, SHANK3 and NRXN2 and also confirmed the affected expression with qPCR. In vitro mouse hippocampal neurons transfected with mutant miR-873 showed less morphological complexity and enhanced sodium currents and excitatory neurotransmission compared to cells transfected with wild-type miR- 873. A second in vitro study showed CRISPR/Cas9 miR-873 disrupted SH-SY5Y neuroblastoma cells acquired a neuronal-like morphology and increased expression of ASD important genes ARID1B, SHANK3, ADNP2, ANK2 and CHD8.
    [Show full text]
  • Synaptic Modulators Nrxn1 and Nrxn3 Are Disregulated in a Disc1 Mouse
    Letters to the Editor 585 National University of Ireland Galway, Galway, Ireland; 4Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA; 5Center for Integrated Molecular Brain Imaging, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark and 6Department of Psychiatry, Laureate Institute for Brain Research, University of Oklahoma College of Medicine, Tulsa, OK, USA E-mail: [email protected] 7These senior authors contributed equally to this paper. References 1 Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M et al. Biological Psychiatry 2002; 51: 715–722. 2 Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS et al. Biol Psychiatry 2007; 15: 870–877. 3 Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK et al. Biol Psychiatry 2006; 60: 207–217. 4 Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. American Journal of Human Genetics 2007; 81: 559–575. Figure 1 Map of t-values from voxel-wise analysis of 5 Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F et al. Synapse 2003; 48: 184–188. rs6741892, overlaid on a sample axial magnetic resonance 6 Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, imaging slice at the level of the medial thalamus (z = 6 mm). Nielsen FA et al. Neuroimage 2009; 45: 280–285. Bilaterally, T-allele carriers (n = 13) have greater serotonin- 7 Erritzoe D, Holst K, Frokjaer VG, Licht CL, Kalbitzer J, Nielsen FA transporter-binding potential than AA homozygotes (n = 42).
    [Show full text]
  • Downregulation of Glial Genes Involved in Synaptic Function
    RESEARCH ARTICLE Downregulation of glial genes involved in synaptic function mitigates Huntington’s disease pathogenesis Tarik Seref Onur1,2,3†, Andrew Laitman2,4,5†, He Zhao2, Ryan Keyho2, Hyemin Kim2, Jennifer Wang2, Megan Mair1,2,3, Huilan Wang6, Lifang Li1,2, Alma Perez2, Maria de Haro1,2, Ying-Wooi Wan2, Genevera Allen2,7, Boxun Lu6, Ismael Al-Ramahi1,2, Zhandong Liu2,4,5, Juan Botas1,2,3,4* 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States; 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States; 3Genetics & Genomics Graduate Program, Baylor College of Medicine, Houston, United States; 4Quantitative & Computational Biosciences, Baylor College of Medicine, Houston, United States; 5Department of Pediatrics, Baylor College of Medicine, Houston, United States; 6State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China; 7Departments of Electrical & Computer Engineering, Statistics and Computer Science, Rice University, Houston, United States Abstract Most research on neurodegenerative diseases has focused on neurons, yet glia help form and maintain the synapses whose loss is so prominent in these conditions. To investigate the contributions of glia to Huntington’s disease (HD), we profiled the gene expression alterations of *For correspondence: Drosophila expressing human mutant Huntingtin (mHTT) in either glia or neurons and compared [email protected] these changes to what is observed in HD human and HD mice striata. A large portion of conserved genes are concordantly dysregulated across the three species; we tested these genes in a high- †These authors contributed throughput behavioral assay and found that downregulation of genes involved in synapse assembly equally to this work mitigated pathogenesis and behavioral deficits.
    [Show full text]
  • Scientists Home in on Autism Candidate Gene's Role in Brain
    Spectrum | Autism Research News https://www.spectrumnews.org NEWS Scientists home in on autism candidate gene’s role in brain BY EMILY SINGER 26 NOVEMBER 2012 Friendly neighborhood: Cells lacking neuroligin-1 have a normal number of synapses (top), but lose them when their neighboring cells express the protein (bottom). Friendly neighborhood: Cells lacking neuroligin-1 have a normal number of synapses (top), but lose them when their neighboring cells express the protein (bottom). Four new studies of neuroligin-1 (NLGN1), a gene linked to autism, unravel its complex role in regulating synapses, the connections between neurons. Three of the studies, published 18 October in Neuron1,2,3, find that the NLGN1 protein is involved in both strengthening and weakening synapses. A fourth, published 8 November in Nature Neuroscience, shows that its role is highly dependent on the environment4. NLGN1 is a member of a family of four proteins known to be involved in synapse maturation5 and maintenance. The proteins were first linked to autism in 2003, when researchers discovered mutations in NLGN4 in two brothers with autism. A mutation in NLGN1 and a duplication of the gene have been found in two individuals with autism6. 1 / 4 Spectrum | Autism Research News https://www.spectrumnews.org Better understanding of the function of these proteins may help researchers understand how mutations in them contribute to autism risk. “A lot of people are interested in NLGN1, because it’s part of a gene family that comes up again and again in autism, but we really don’t understand what it does,” says Bernardo Sabatini, professor of molecular biology at Harvard Medical School and lead investigator of the Nature Neuroscience paper.
    [Show full text]
  • Genome-Wide Copy Number Variation Analysis in a Chinese Autism
    www.nature.com/scientificreports OPEN Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort Received: 11 November 2016 Hui Guo1,2,*, Yu Peng1,*, Zhengmao Hu1, Ying Li1, Guanglei Xun3, Jianjun Ou2, Liangdan Sun4, Accepted: 03 February 2017 Zhimin Xiong5, Yanling Liu1, Tianyun Wang1, Jingjing Chen1, Lu Xia1, Ting Bai1, Yidong Shen2, Published: 10 March 2017 Qi Tian1, Yiqiao Hu1, Lu Shen1, Rongjuan Zhao1, Xuejun Zhang4, Fengyu Zhang2,6, Jingping Zhao2, Xiaobing Zou7 & Kun Xia1,8,9 Autism spectrum disorder (ASD) describes a group of neurodevelopmental disorders with high heritability, although the underlying genetic determinants of ASDs remain largely unknown. Large- scale whole-genome studies of copy number variation in Han Chinese samples are still lacking. We performed a genome-wide copy number variation analysis of 343 ASD trios, 203 patients with sporadic cases and 988 controls in a Chinese population using Illumina genotyping platforms to identify CNVs and related genes that may contribute to ASD risk. We identified 32 rare CNVs larger than 1 Mb in 31 patients. ASD patients were found to carry a higher global burden of rare, large CNVs than controls. Recurrent de novo or case-private CNVs were found at 15q11-13, Xp22.3, 15q13.1–13.2, 3p26.3 and 2p12. The de novo 15q11–13 duplication was more prevalent in this Chinese population than in those with European ancestry. Several genes, including GRAMD2 and STAM, were implicated as novel ASD risk genes when integrating whole-genome CNVs and whole-exome sequencing data. We also identified several CNVs that include known ASD genes (SHANK3, CDH10, CSMD1) or genes involved in nervous system development (NYAP2, ST6GAL2, GRM6).
    [Show full text]
  • Mycobacterium Tuberculosis-Induced Maternal Immune Activation Promotes Autism-Like Phenotype in Infected Mice Offspring
    International Journal of Environmental Research and Public Health Article Mycobacterium tuberculosis-Induced Maternal Immune Activation Promotes Autism-Like Phenotype in Infected Mice Offspring Wadzanai Manjeese 1 , Nontobeko E. Mvubu 2 , Adrie J. C. Steyn 2,3,4 and Thabisile Mpofana 1,* 1 Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa; [email protected] 2 Discipline of Microbiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban 4001, South Africa; [email protected] (N.E.M.); [email protected] (A.J.C.S.) 3 Africa Health Research Institute, K-Rith Tower Building, Nelson Mandela School of Medicine, Durban 4001, South Africa 4 Department of Microbiology, University of Alabama, Birmingham, AL 35294, USA * Correspondence: [email protected] Abstract: The maternal system’s exposure to pathogens during pregnancy influences fetal brain development causing a persistent inflammation characterized by elevated pro-inflammatory cytokine levels in offspring. Mycobacterium tuberculosis (Mtb) is a global pathogen that causes tuberculosis, a pandemic responsible for health and economic burdens. Although it is known that maternal Citation: Manjeese, W.; Mvubu, N.E.; infections increase the risk of autism spectrum disorder (ASD), it is not known whether Mtb infection Steyn, A.J.C.; Mpofana, T. is sufficient to induce ASD associated behaviors, immune dysregulation and altered expression Mycobacterium tuberculosis-Induced of synaptic regulatory genes. The current study infected pregnant Balb/c mice with Mtb H37Rv Maternal Immune Activation and valproic acid (VPA) individually and in combination. Plasma cytokine profiles were measured Promotes Autism-Like Phenotype in Infected Mice Offspring.
    [Show full text]
  • Fibroblasts from the Human Skin Dermo-Hypodermal Junction Are
    cells Article Fibroblasts from the Human Skin Dermo-Hypodermal Junction are Distinct from Dermal Papillary and Reticular Fibroblasts and from Mesenchymal Stem Cells and Exhibit a Specific Molecular Profile Related to Extracellular Matrix Organization and Modeling Valérie Haydont 1,*, Véronique Neiveyans 1, Philippe Perez 1, Élodie Busson 2, 2 1, 3,4,5,6, , Jean-Jacques Lataillade , Daniel Asselineau y and Nicolas O. Fortunel y * 1 Advanced Research, L’Oréal Research and Innovation, 93600 Aulnay-sous-Bois, France; [email protected] (V.N.); [email protected] (P.P.); [email protected] (D.A.) 2 Department of Medical and Surgical Assistance to the Armed Forces, French Forces Biomedical Research Institute (IRBA), 91223 CEDEX Brétigny sur Orge, France; [email protected] (É.B.); [email protected] (J.-J.L.) 3 Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, 91000 Evry, France 4 INSERM U967, 92260 Fontenay-aux-Roses, France 5 Université Paris-Diderot, 75013 Paris 7, France 6 Université Paris-Saclay, 78140 Paris 11, France * Correspondence: [email protected] (V.H.); [email protected] (N.O.F.); Tel.: +33-1-48-68-96-00 (V.H.); +33-1-60-87-34-92 or +33-1-60-87-34-98 (N.O.F.) These authors contributed equally to the work. y Received: 15 December 2019; Accepted: 24 January 2020; Published: 5 February 2020 Abstract: Human skin dermis contains fibroblast subpopulations in which characterization is crucial due to their roles in extracellular matrix (ECM) biology.
    [Show full text]
  • Sex-Linked Neuroligins and Their Roles at Synapses A
    SEX-LINKED NEUROLIGINS AND THEIR ROLES AT SYNAPSES A Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Pharmacology By Thien Anh Nguyen, B.S. Washington, D.C. March 3, 2020 Copyright 2020 by Thien A. Nguyen All Rights Reserved ii SEX-LINKED NEUROLIGINS AND THEIR ROLES AT SYNAPSES Thien A Nguyen, B.S. Thesis Advisor: Katherine W. Roche, PhD ABSTRACT Autism spectrum disorder (ASD) is a neurodevelopmental disorder that results in social- communication impairments, restricted and repetitive behaviors, and is more prevalent in males. Although the underlying etiology of ASD is generally unknown, a cell adhesion molecule, Neuroligin 4X (NLGN4X) located on the X chromosome, has been specifically linked with this disorder. The male-specific NLGN4Y, the NLGN4X homolog, is thought to be functionally redundant, but this assumption has not been experimentally tested. In this dissertation, we report NLGN4X and NLGN4Y are functionally different. NLGN4Y does not effectively traffic to the surface or induce synapses. We show that a critical amino acid difference in the extracellular domain (ECD) between NLGN4X (P93) and NLGN4Y (S93) leads to this differential function. In addition, we show that NLGN4X is robustly phosphorylated by protein kinase A and protein kinase C, whereas NLGN4Y cannot. The differential phosphorylation is due to one amino acid difference in the intracellular domain (ICD) between NLGN4X (R710) and NLGN4Y (H710). Together, we demonstrate that NLGN4X and NLGN4Y do not share the same function. Interestingly, many ASD-associated variants have been identified in NLGN4X in the region surrounding P93, and there is a decrease in normal population variation in this region.
    [Show full text]
  • Cartography of Neurexin Alternative Splicing Mapped by Single
    Cartography of neurexin alternative splicing mapped PNAS PLUS by single-molecule long-read mRNA sequencing Barbara Treutleina,b,1, Ozgun Gokcec,1, Stephen R. Quakea,b,d,2, and Thomas C. Südhofc,d,2 Departments of aBioengineering and cMolecular and Cellular Physiology, School of Medicine, bDepartment of Applied Physics, and dHoward Hughes Medical Institute, Stanford University, Stanford, CA 94305 Contributed by Thomas C. Südhof, February 24, 2014 (sent for review January 24, 2014) Neurexins are evolutionarily conserved presynaptic cell-adhesion α-andβ-neurexins contain different extracellular sequences molecules that are essential for normal synapse formation and but identical transmembrane regions and short cytoplasmic tails. synaptic transmission. Indirect evidence has indicated that exten- Specifically, the extracellular sequences of α-neurexins are sive alternative splicing of neurexin mRNAs may produce hundreds composed of six LNS (laminin-α, neurexin, sex hormone-binding if not thousands of neurexin isoforms, but no direct evidence for globulin) domains with three interspersed EGF-like repeats such diversity has been available. Here we use unbiased long-read followed by an O-linked sugar attachment sequence and a con- sequencing of full-length neurexin (Nrxn)1α, Nrxn1β,Nrxn2β, served cysteine loop sequence (8, 15). In contrast, the extracel- Nrxn3α, and Nrxn3β mRNAs to systematically assess how many lular sequences of β-neurexins comprise a short β-neurexin– sites of alternative splicing are used in neurexins with a significant specific sequence, and then splice into the sixth LNS domain of frequency, and whether alternative splicing events at these sites α-neurexins, from which point on β-neurexins are identical to are independent of each other.
    [Show full text]
  • Molecular Mechanisms: Researchers Light up Interactions Between Neurons
    Spectrum | Autism Research News https://www.spectrumnews.org NEWS Molecular mechanisms: Researchers light up interactions between neurons BY JESSICA WRIGHT 30 NOVEMBER 2010 Pretty picture: Engineered neuroligins (green) and neurexins (blue) bind at the sites of communication (red) between neurons. Researchers have developed a technique to detect interactions in live neurons between neuroligins and neurexins — two proteins known to bind at the junction between neurons, according to a study published 29 October in Cell. Neurons relay information across the brain by releasing molecules, called neurotransmitters, across synapses, the junctions between neurons. Neurexins and neuroligins, which jut out of the transmitting and receiving ends of neurons, respectively, bind to each other on neighboring cells, stabilizing an active synapse. Researchers induced some live neurons, removed from a rat hippocampus, to express an engineered version of neurexin-1 (NRXN1) that can add a small molecule called biotin to another protein. They then induced other neurons to express a modified form of neuroligin-1 (NLGN1) that has a biotin-receiving domain. When the two proteins bind at a synapse, the modified NRXN1 attaches biotin to the modified NLGN1. Using this clever technique and a fluorescent dye that binds to biotin, the researchers can look at 1 / 2 Spectrum | Autism Research News https://www.spectrumnews.org the live interaction between NRXN1 and NLGN1. They can also detect the number of interactions by quantifying the fluorescent signal. When the neurons release neurotransmitters, the researchers found, the engineered proteins interact more. This suggests that NLGN1-NRXN1 interactions increase in an active synapse. Using dyes to distinguish interactions before and after activation, the researchers show that neuron activation increases the amount NRXN1 and NLGN1 at the cell surface.
    [Show full text]
  • Human Neuroligin 1 / NLGN1 Protein (His Tag)
    Human Neuroligin 1 / NLGN1 Protein (His Tag) Catalog Number: 11617-H08H General Information SDS-PAGE: Gene Name Synonym: NL1 Protein Construction: A DNA sequence encoding the human NLGN1 (NP_055747.1) extracellular domain (Met 1-Ser 677) was expressed, fused with a polyhistidine tag at the C-terminus. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 97 % as determined by SDS-PAGE Endotoxin: Protein Description < 1.0 EU per μg of the protein as determined by the LAL method Neuroligin 1 (NLGN1) belongs to the type-B carboxylesterase/lipase family, is a synaptic cell-adhesion molecule that is enriched in postsynaptic Stability: densities where it may recruit receptors, channels, and signal-transduction molecules to synaptic sites of cell adhesion. Neuroligins consist of five ℃ Samples are stable for up to twelve months from date of receipt at -70 members (NLGN1, NLGN2, NLGN3, NLGN4 and NLGN4Y), which interact with beta-neurexins and this interaction is involved in the formation of Gln 46 Predicted N terminal: functional synapses. The extracellular domain of functional Neuroligin 1 Molecular Mass: associates as a dimer when analyzed by sedimentation equilibrium. Neuroligin 1 has a unique N-linked glycosylation pattern in the neuroligin The recombinant human NLGN1 consists of 643 amino acids and family, and glycosylation and its processing modify neuroligin activity. predictes a molecular mass of 72 kDa. In SDS-PAGE under reducing Neuroligin 1 is a potent trigger for the de novo formation of synaptic conditions, the apparent molecular mass of rhNLGN1 is approximately 85- connections, and it has recently been suggested that it is required for the 95 kDa due to glycosylation.
    [Show full text]